EPIGENESIS

Serial Number 76113581
606

Registration Progress

Application Filed
Aug 16, 2000
Under Examination
Jan 7, 2003
Approved for Publication
Sep 25, 2002
Published for Opposition
Oct 15, 2002
Registered

Trademark Image

EPIGENESIS

Basic Information

Serial Number
76113581
Filing Date
August 16, 2000
Published for Opposition
October 15, 2002
Abandonment Date
January 8, 2006
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 8, 2006
Classes
005

Rights Holder

EPIGENESIS PHARMACEUTICALS LLC

03
Address
7 CLARKE DRIVE
CRANBURY, NJ 08512

Ownership History

EPIGENESIS Pharmaceuticals, Inc.

Original Applicant
03
Cranbury, NJ

EPIGENESIS Pharmaceuticals, Inc.

Owner at Publication
03
Cranbury, NJ

EPIGENESIS PHARMACEUTICALS, INC.

New Owner After Publication #1
03
CRANBURY, NJ

EPIGENESIS PHARMACEUTICALS LLC

New Owner After Publication #2
03
CRANBURY, NJ

Legal Representation

Attorney
Viviana Amzel

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

30 events
Date Code Type Description Documents
Mar 14, 2006 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 14, 2006 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jul 1, 2005 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 1, 2005 EXT5 S SOU EXTENSION 5 FILED Loading...
Jul 1, 2005 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jan 10, 2005 EX4G S SOU EXTENSION 4 GRANTED Loading...
Dec 23, 2004 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 23, 2004 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 30, 2004 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 19, 2004 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 16, 2004 MAIL I PAPER RECEIVED Loading...
Jul 13, 2004 CFIT O CASE FILE IN TICRS Loading...
Jul 6, 2004 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 6, 2004 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 7, 2004 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 7, 2004 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 7, 2004 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 9, 2003 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 3, 2003 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 3, 2003 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 7, 2003 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 15, 2002 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 25, 2002 NPUB O NOTICE OF PUBLICATION Loading...
Jul 15, 2002 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 10, 2002 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 10, 2002 1.BA I Sec. 1(B) CLAIM ADDED Loading...
May 10, 2002 1.AD I SEC. 1(A) CLAIM DELETED Loading...
Nov 29, 2001 CNFR O FINAL REFUSAL MAILED Loading...
Aug 17, 2001 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 12, 2001 CNRT F NON-FINAL ACTION MAILED Loading...

Detailed Classifications

Class 005
Medical, diagnostic and therapeutic preparations and devices for administering same, sold filled, with diagnostic and therapeutic preparations, all for administration via diverse routes of administration, including through the respiratory airways, and medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms, pharmaceutical preparations for testing and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as all metastatic cancers, eg
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005